Limitations of the radioreceptor assay of inositol 1,4,5-trisphosphate in vanadate-treated cell suspensions.
作者信息
Sandirasegarane L, Gopalakrishnan V
出版信息
Biochem J. 1994 Mar 1;298 ( Pt 2)(Pt 2):511-2. doi: 10.1042/bj2980511.
Abstract
摘要
相似文献
1
Limitations of the radioreceptor assay of inositol 1,4,5-trisphosphate in vanadate-treated cell suspensions.
Biochem J. 1994 Mar 1;298 ( Pt 2)(Pt 2):511-2. doi: 10.1042/bj2980511.
2
Measurement of inositol(1,4,5)trisphosphate using a stereospecific radioreceptor mass assay.
Methods Mol Biol. 2006;312:195-203.
3
A radioreceptor assay for mass measurement of inositol (1,4,5)-trisphosphate using saponin-permeabilized outdated human platelets.
Anal Biochem. 1998 Feb 1;256(1):117-21. doi: 10.1006/abio.1997.2488.
4
Inositol 1,4,5-trisphosphate mass assay.
Methods Mol Biol. 1998;105:77-87. doi: 10.1385/0-89603-491-7:77.
5
Measurement of inositol(1,4,5)trisphosphate using a stereospecific radioreceptor mass assay.
Methods Mol Biol. 1999;114:175-83. doi: 10.1385/1-59259-250-3:175.
6
Localization of inositol 1,4,5-trisphosphate receptors in the rat kidney.
Kidney Int. 1998 Feb;53(2):296-301. doi: 10.1046/j.1523-1755.1998.00763.x.
7
Measurement of inositol(1,4,5)trisphosphate using a stereospecific radioreceptor mass assay.
Methods Mol Biol. 2013;937:193-203. doi: 10.1007/978-1-62703-086-1_11.
8
Metabolism of inositol 1,4,5-trisphosphate in permeabilized rat aortic smooth-muscle cells. Dependence on calcium concentration.
Biochem J. 1987 Jul 1;245(1):305-7. doi: 10.1042/bj2450305.
9
Nitric oxide selectively inhibits intracellular Ca++ release elicited by inositol trisphosphate but not caffeine in rat vascular smooth muscle.
J Pharmacol Exp Ther. 1998 Apr;285(1):16-21.
10
Is decavanadate a specific inositol 1,4,5-trisphosphate receptor antagonist?
Biochem J. 1991 Jul 1;277 ( Pt 1)(Pt 1):294. doi: 10.1042/bj2770294a.
本文引用的文献
1
Peroxovanadate but not vanadate exerts insulin-like effects in human adipocytes.
Diabetologia. 1993 Feb;36(2):113-6. doi: 10.1007/BF00400690.
2
Cytosolic [Ca2+] homeostasis and tyrosine phosphorylation of phospholipase C gamma 2 in HL60 granulocytes.
J Biol Chem. 1993 Feb 15;268(5):3357-63.
3
Peroxide(s) of vanadium: a novel and potent insulin-mimetic agent which activates the insulin receptor kinase.
Biochem Biophys Res Commun. 1987 Aug 31;147(1):259-66. doi: 10.1016/s0006-291x(87)80115-8.
4
Stimulation of insulin-like growth factor II receptor binding and insulin receptor kinase activity in rat adipocytes. Effects of vanadate and H2O2.
J Biol Chem. 1987 Jun 15;262(17):8252-6.
5
Characterization of the inositol 1,4,5-trisphosphate-induced calcium release from permeabilized endocrine cells and its inhibition by decavanadate and p-hydroxymercuribenzoate.
Biochem J. 1989 Aug 15;262(1):83-9. doi: 10.1042/bj2620083.
6
Heterogeneity of [3H]inositol 1,4,5-trisphosphate binding sites in adrenal-cortical membranes. Characterization and validation of a radioreceptor assay.
Biochem J. 1990 Jan 15;265(2):421-7. doi: 10.1042/bj2650421.
7
Vasopressin (V1) receptor characteristics in rat aortic smooth muscle cells.
Am J Physiol. 1991 Dec;261(6 Pt 2):H1927-36. doi: 10.1152/ajpheart.1991.261.6.H1927.
8
Decavanadate displaces inositol 1,4,5-trisphosphate (IP3) from its receptor and inhibits IP3 induced Ca2+ release in permeabilized pancreatic acinar cells.
Cell Calcium. 1991 Nov;12(10):735-42. doi: 10.1016/0143-4160(91)90042-d.
9
Rapid increase of inositol 1,4,5-trisphosphate content in isolated rat adipose tissue by vanadate.
Chem Pharm Bull (Tokyo). 1992 Aug;40(8):2242-4. doi: 10.1248/cpb.40.2242.
10
The effect of orthovanadate on phosphoinositide metabolism in NIH 3T3 fibroblasts.
Arch Biochem Biophys. 1992 Jan;292(1):258-65. doi: 10.1016/0003-9861(92)90077-a.
Zotero 插件